Bile acid analysis in biliary tract cancer
- PMID: 17191311
- PMCID: PMC2687822
- DOI: 10.3349/ymj.2006.47.6.817
Bile acid analysis in biliary tract cancer
Abstract
The etiology of biliary tract cancer is obscure, but there are evidences that bile acid plays a role in carcinogenesis. To find the association between biliary tract cancer and bile acid, this study compared the bile acid concentration and composition among patients with biliary cancer, biliary tract stones, and no biliary disease. Bile was compared among patients with biliary tract cancer (n = 26), biliary tract stones (n = 29), and disease free controls (n = 9). Samples were obtained by percutaneous transhepatic biliary drainage, endoscopic nasobiliary drainage, or gallbladder puncture, and analyzed for cholic, deoxycholic, chenodeoxycholic, lithocholic, and ursodeoxycholic acid composition. Total bile acid concentration was lower in the cancer group than the biliary stone and control groups; the proportions of deoxycholic (2.2% vs. 10.2% and 23.6%, p < 0.001 and p < 0.001, respectively) and lithocholic acid (0.3% vs. 0.6% and 1.0%, p = 0.065 and p < 0.001, respectively) were also lower. This result was similar when disease site was limited to bile duct or gallbladder. Analysis of cases with bilirubin <or= 2.0 mg/dL also showed lower total bile acid concentration and deoxycholic acid composition in the cancer group compared to controls (5.7% vs. 23.6%, p = 0.003). Although the presence of bile duct obstruction explains some of the difference in total concentration and composition of bile acid, there are other contributing mechanisms. We suspect the alteration of bile acid transport might decrease bile acid excretion and cause the accumulation of carcinogenic bile acid in bile duct epithelium.
Similar articles
-
Biochemical epidemiology of gallbladder cancer.Hepatology. 1996 Jun;23(6):1402-11. doi: 10.1002/hep.510230616. Hepatology. 1996. PMID: 8675157
-
Biliary bile acids in cholelithiasis and carcinoma of the gall bladder.Eur J Cancer Prev. 1993 Mar;2(2):155-60. doi: 10.1097/00008469-199303000-00008. Eur J Cancer Prev. 1993. PMID: 8461866
-
Role of bile bacteria in gallbladder carcinoma.Hepatogastroenterology. 2007 Sep;54(78):1622-5. Hepatogastroenterology. 2007. PMID: 18019679
-
Bile liquid biopsy in biliary tract cancer.Clin Chim Acta. 2023 Nov 1;551:117593. doi: 10.1016/j.cca.2023.117593. Epub 2023 Oct 13. Clin Chim Acta. 2023. PMID: 37839517 Review.
-
Advances in omics-based biomarker discovery for biliary tract malignancy Diagnosis:A narrative review.Mol Cell Probes. 2024 Aug;76:101970. doi: 10.1016/j.mcp.2024.101970. Epub 2024 Jul 6. Mol Cell Probes. 2024. PMID: 38964426 Review.
Cited by
-
Research progress of bile biomarkers and their immunoregulatory role in biliary tract cancers.Front Immunol. 2022 Oct 28;13:1049812. doi: 10.3389/fimmu.2022.1049812. eCollection 2022. Front Immunol. 2022. PMID: 36389727 Free PMC article. Review.
-
Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines.World J Gastroenterol. 2008 Apr 28;14(16):2578-81. doi: 10.3748/wjg.14.2578. World J Gastroenterol. 2008. PMID: 18442209 Free PMC article.
-
Distinct composition and metabolic potential of biliary microbiota in patients with malignant bile duct obstruction.Eur J Gastroenterol Hepatol. 2025 May 1;37(5):585-593. doi: 10.1097/MEG.0000000000002948. Epub 2025 Mar 26. Eur J Gastroenterol Hepatol. 2025. PMID: 40207470 Free PMC article.
-
Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.Cancers (Basel). 2022 Aug 13;14(16):3921. doi: 10.3390/cancers14163921. Cancers (Basel). 2022. PMID: 36010914 Free PMC article. Review.
-
The value of grip test, lysophosphatidlycholines, glycerophosphocholine, ornithine, glucuronic acid decrement in assessment of nutritional and metabolic characteristics in hepatitis B cirrhosis.PLoS One. 2017 Apr 6;12(4):e0175165. doi: 10.1371/journal.pone.0175165. eCollection 2017. PLoS One. 2017. PMID: 28384211 Free PMC article.
References
-
- Javitt NB. Bile acid synthesis from cholesterol: regulatory and auxiliary pathways. FASEB J. 1994;8:1308–1311. - PubMed
-
- Cameron RG, Imaida K, Tsuda H, Ito N. Promotive effect of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res. 1982;42:2426–2428. - PubMed
-
- Makino T, Obara T, Ura H, Kinugasa T, Kobayashi H, Takahashi S, et al. Effects of phenobarbital and secondary bile acids on liver, gallbladder, and pancreas carcinogenesis initiated by N-nitrosobis (2-hydroxypropyl) amine in hamsters. J Natl Cancer Inst. 1986;76:967–975. - PubMed
-
- Thompson MB. Bile acids in assessment of hepatocellular function. Toxicol Pathol. 1996;24:62–71. - PubMed
-
- Einarsson K. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism. Scand J Gastroenterol Suppl. 1994;204:19–23. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources